Impact of time to diagnosis in patients with progressive fibrotic ILD: a systematic review
Zhongyi Deng, Stefan Karrasch, Peter Alter, Pilar Rivera-Ortega, Juergen Behr, Rudolf Jörres · 2026
Read Impact of time to diagnosis in patients with progressive fibrotic ILD: a systematic review by Zhongyi Deng, Stefan Karrasch, Peter Alter, Pilar Rivera-Ortega, Juergen Behr, Rudolf Jörres (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13599957.txt.
Description
Zhongyi Deng and five co-authors reviewed in 2026 how long it takes to diagnose progressive scarring lung diseases, and what the wait costs patients. They gathered thirty-four studies covering over thirty-six thousand patients in forty-one countries. The median wait from first symptoms ran from six to about twenty-five months. Between a third and three quarters of patients waited over a year.
Breathlessness, cough and tiredness were the usual first signs, and a fifth to nearly nine tenths of patients were first misdiagnosed, often with heart or other lung trouble. Longer waits tracked worse disease, survival, life quality and more hospital stays. Older age, other illnesses and missing early scans or team review all predicted delay. The authors call the cost picture itself under-studied. They urge faster routes to specialist judgment.
Catalog record
| CREATOR | Zhongyi Deng, Stefan Karrasch, Peter Alter, Pilar Rivera-Ortega, Juergen Behr, Rudolf Jörres |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |